PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial

Brown, H.Vansteenkiste, J.Nakagawa, K.Cobo Dols, M.John, T.Barker, C.Kohlmann, A.Todd, A.Saggese, M.Chmielecki, J.Markovets, A.Ramalingam, S.2025-01-072025-01-072018-10-011556-0864https://hdl.handle.net/10668/24449enPD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trialconference outputopen access10.1016/j.jtho.2018.08.4411556-1380http://www.jto.org/article/S1556086418313996/pdf454014501078